Free Trial

Cardinal Health (CAH) Competitors

$99.27
+1.56 (+1.60%)
(As of 05/31/2024 ET)

CAH vs. MCK, COR, HSIC, PDCO, OMI, HLF, NUS, PETQ, HWH, and BIMI

Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include McKesson (MCK), Cencora (COR), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), HWH International (HWH), and BIMI (BIMI).

Cardinal Health vs.

McKesson (NYSE:MCK) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking.

McKesson has a net margin of 0.97% compared to McKesson's net margin of 0.25%. McKesson's return on equity of -54.74% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.97% -245.88% 5.57%
Cardinal Health 0.25%-54.74%3.98%

McKesson received 47 more outperform votes than Cardinal Health when rated by MarketBeat users. Likewise, 74.16% of users gave McKesson an outperform vote while only 71.70% of users gave Cardinal Health an outperform vote.

CompanyUnderperformOutperform
McKessonOutperform Votes
944
74.16%
Underperform Votes
329
25.84%
Cardinal HealthOutperform Votes
897
71.70%
Underperform Votes
354
28.30%

McKesson has higher revenue and earnings than Cardinal Health. McKesson is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$308.95B0.24$3.00B$22.3825.45
Cardinal Health$220.57B0.11$261M$2.2544.12

McKesson has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.

McKesson pays an annual dividend of $2.48 per share and has a dividend yield of 0.4%. Cardinal Health pays an annual dividend of $2.02 per share and has a dividend yield of 2.0%. McKesson pays out 11.1% of its earnings in the form of a dividend. Cardinal Health pays out 89.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. McKesson has raised its dividend for 16 consecutive years and Cardinal Health has raised its dividend for 27 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, McKesson had 26 more articles in the media than Cardinal Health. MarketBeat recorded 36 mentions for McKesson and 10 mentions for Cardinal Health. McKesson's average media sentiment score of 0.68 beat Cardinal Health's score of 0.57 indicating that Cardinal Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
12 Very Positive mention(s)
7 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardinal Health
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson currently has a consensus target price of $571.47, suggesting a potential upside of 0.33%. Cardinal Health has a consensus target price of $107.57, suggesting a potential upside of 8.36%. Given McKesson's higher probable upside, analysts clearly believe Cardinal Health is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.87
Cardinal Health
1 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

85.1% of McKesson shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.2% of McKesson shares are held by company insiders. Comparatively, 0.2% of Cardinal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

McKesson beats Cardinal Health on 13 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$24.18B$15.07B$5.13B$17.78B
Dividend Yield2.08%1.29%2.75%3.55%
P/E Ratio44.1218.22158.4625.84
Price / Sales0.111.912,416.7211.48
Price / Cash11.259.7835.3318.95
Price / Book-7.418.605.535.90
Net Income$261M$618.02M$106.01M$976.46M
7 Day Performance2.99%1.88%1.14%0.62%
1 Month Performance-3.60%1.09%0.69%3.61%
1 Year Performance17.35%3.12%2.66%20.81%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.7077 of 5 stars
$549.16
-2.1%
$571.47
+4.1%
+46.3%$71.39B$308.95B24.5451,000Insider Selling
Analyst Revision
COR
Cencora
4.205 of 5 stars
$216.21
-1.2%
$233.90
+8.2%
+31.3%$43.12B$262.17B23.6646,000Insider Buying
HSIC
Henry Schein
3.8443 of 5 stars
$71.15
-0.8%
$81.73
+14.9%
-5.6%$9.11B$12.45B24.0425,000Short Interest ↑
Analyst Revision
PDCO
Patterson Companies
4.2902 of 5 stars
$23.98
+0.2%
$31.67
+32.1%
-6.4%$2.15B$6.47B11.817,600Analyst Downgrade
Analyst Revision
OMI
Owens & Minor
4.514 of 5 stars
$17.29
-1.4%
$23.29
+34.7%
-15.2%$1.32B$10.33B-33.9013,700Positive News
HLF
Herbalife
3.3577 of 5 stars
$10.82
+0.6%
$10.50
-2.9%
-13.4%$1.08B$5.06B7.899,200Analyst Upgrade
NUS
Nu Skin Enterprises
4.7395 of 5 stars
$13.34
+0.8%
$20.83
+56.2%
-60.4%$662.35M$1.97B-222.213,700Positive News
PETQ
PetIQ
3.8327 of 5 stars
$19.91
+0.6%
$29.00
+45.7%
+57.5%$592.32M$1.10B90.501,933Positive News
HWH
HWH International
0 of 5 stars
$1.30
+10.2%
N/AN/A$21.09MN/A0.00N/AShort Interest ↓
Positive News
Gap Down
BIMI
BIMI
0 of 5 stars
$1.09
+1.9%
N/A+10.6%$12.63M$11.83M0.00296Short Interest ↓
Gap Up

Related Companies and Tools

This page (NYSE:CAH) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners